Literature DB >> 29440322

Neurodegeneration in Progressive Multiple Sclerosis.

Graham Campbell1, Don Mahad1.   

Abstract

The neuron is the target of inflammatory demyelinating processes in multiple sclerosis (MS). In progressive MS, however, there is a gathering body of evidence indicating molecular changes within neuronal cell bodies. All of these molecular changes to intrinsic neurons converge on mitochondria, and the most reproduced change relates to mitochondrial respiratory chain complex deficiency. This compromise in the capacity to generate ATP in the neuronal cell body is coupled with an increased demand for energy by the demyelinated axon, which is particularly relevant to the long tracts such as corticospinal tracts with long projection axons. Recent work in our laboratory and that of our collaborators indicate limited reflection of the molecular changes that are intrinsic neurons in the experimental disease models. The mitochondrial changes within neuronal compartments are an under-recognized aspect of progressive MS and likely to offer novel targets for the improvement of neuronal function as well as neuroprotection.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29440322      PMCID: PMC6169982          DOI: 10.1101/cshperspect.a028985

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  37 in total

1.  Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.

Authors:  Tanja Jürgens; Mehrnoosh Jafari; Mario Kreutzfeldt; Erik Bahn; Wolfgang Brück; Martin Kerschensteiner; Doron Merkler
Journal:  Brain       Date:  2015-12-14       Impact factor: 13.501

2.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.

Authors:  Ranjan Dutta; Jennifer McDonough; Xinghua Yin; John Peterson; Ansi Chang; Thalia Torres; Tatyana Gudz; Wendy B Macklin; David A Lewis; Robert J Fox; Richard Rudick; Karoly Mirnics; Bruce D Trapp
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

3.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

Authors:  Roberta Magliozzi; Owain W Howell; Cheryl Reeves; Federico Roncaroli; Richard Nicholas; Barbara Serafini; Francesca Aloisi; Richard Reynolds
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

4.  Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis.

Authors:  Stephen G Waxman
Journal:  Trends Mol Med       Date:  2006-03-30       Impact factor: 11.951

5.  Pervasive axonal transport deficits in multiple sclerosis models.

Authors:  Catherine Diamante Sorbara; Naomi Elizabeth Wagner; Anne Ladwig; Ivana Nikić; Doron Merkler; Tatjana Kleele; Petar Marinković; Ronald Naumann; Leanne Godinho; Florence Martine Bareyre; Derron Bishop; Thomas Misgeld; Martin Kerschensteiner
Journal:  Neuron       Date:  2014-11-26       Impact factor: 17.173

6.  Analysis of the mitochondrial proteome in multiple sclerosis cortex.

Authors:  Laurie Broadwater; Ashish Pandit; Robert Clements; Sausan Azzam; Jonathan Vadnal; Michael Sulak; V Wee Yong; Ernest J Freeman; Roger B Gregory; Jennifer McDonough
Journal:  Biochim Biophys Acta       Date:  2011-02-02

7.  Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.

Authors:  Graham R Campbell; Yevgenya Kraytsberg; Kim J Krishnan; Nobuhiko Ohno; Iryna Ziabreva; Amy Reeve; Bruce D Trapp; Jia Newcombe; Richard Reynolds; Hans Lassmann; Konstantin Khrapko; Doug M Turnbull; Don J Mahad
Journal:  Acta Neuropathol       Date:  2012-06-12       Impact factor: 17.088

8.  Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.

Authors:  Jessica L Zambonin; Chao Zhao; Nobuhiko Ohno; Graham R Campbell; Sarah Engeham; Iryna Ziabreva; Nadine Schwarz; Sok Ee Lee; Josa M Frischer; Doug M Turnbull; Bruce D Trapp; Hans Lassmann; Robin J M Franklin; Don J Mahad
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

9.  Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model.

Authors:  Vanessa Hogan; Kathryn White; Julia Edgar; Alison McGill; Saadia Karim; Mark McLaughlin; Ian Griffiths; Doug Turnbull; Philip Nichols
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

10.  No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.

Authors:  Graham R Campbell; Amy K Reeve; Iryna Ziabreva; Richard Reynolds; Doug M Turnbull; Don J Mahad
Journal:  Mult Scler       Date:  2013-06-20       Impact factor: 6.312

View more
  6 in total

1.  In vivo confocal microscopy of corneal nerve fiber damage in early course of multiple sclerosis.

Authors:  Muge Toprak; Ozgul Altintas; Hande Bickin; Husnu Efendi; Busra Yilmaz Tugan; Nursen Yuksel
Journal:  Int Ophthalmol       Date:  2022-08-09       Impact factor: 2.029

Review 2.  PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Pharmacol Ther       Date:  2020-10-09       Impact factor: 12.310

Review 3.  Dynamic glial response and crosstalk in demyelination-remyelination and neurodegeneration processes.

Authors:  Tianci Chu; Lisa B E Shields; Wenxin Zeng; Yi Ping Zhang; Yuanyi Wang; Gregory N Barnes; Christopher B Shields; Jun Cai
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

Review 4.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

Review 5.  Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders.

Authors:  Hanie Yavarpour-Bali; Maryam Ghasemi-Kasman; Marzieh Pirzadeh
Journal:  Int J Nanomedicine       Date:  2019-06-17

Review 6.  Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Authors:  Emily Kamma; Wendy Lasisi; Cole Libner; Huah Shin Ng; Jason R Plemel
Journal:  J Neuroinflammation       Date:  2022-02-10       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.